Industry Reports

Merrion Pharmaceuticals Plc (3MP) - Financial and Strategic SWOT Analysis Review

Friday, Apr 15, 2016

Merrion Pharmaceuticals Plc (Merrion) is a pharmaceutical company that offers prescription pharmaceutical products to meet unmet needs in healthcare. The company’s product pipeline includes Orazol breast cancer, Orazol bone metastases, Almerol (MER-103), Acyline (MER-104) and MER-102. It offers its products in drug forms such as tablets, capsules and injections. Merrion’s products are used to treat therapeutic areas suuh as bone metastases, breast cancer, osteoporosis, prostate cancer and deep vein thrombosis. The company has agreements with several pharmaceutical companies. Merrion is headquartered in Dublin, Ireland.

Read More>